APOBEC3G (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "APOBEC3G" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

5^th place

19^th place

3,555^th place

2,938^th place

4sciencedirect.com

149^th place

558^th place

18^th place

107^th place

1,626^th place

2,625^th place

low place

low place

low place

low place

1,293^rd place

1,250^th place

asm.org

jvi.asm.org

Huthoff, Hendrik; Malim, Michael H. (2007-04-15). “Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation” (英語). Journal of Virology 81 (8): 3807–3815. doi:10.1128/JVI.02795-06. ISSN 0022-538X. PMC 1866099. PMID 17267497. https://jvi.asm.org/content/81/8/3807.
Mbisa, Jean L.; Barr, Rebekah; Thomas, James A.; Vandegraaff, Nick; Dorweiler, Irene J.; Svarovskaia, Evguenia S.; Brown, William L.; Mansky, Louis M. et al. (2007-07-01). “Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration” (英語). Journal of Virology 81 (13): 7099–7110. doi:10.1128/JVI.00272-07. ISSN 0022-538X. PMC 1933301. PMID 17428871.
Sadler, Holly A.; Stenglein, Mark D.; Harris, Reuben S.; Mansky, Louis M. (2010-07-15). “APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis” (英語). Journal of Virology 84 (14): 7396–7404. doi:10.1128/JVI.00056-10. ISSN 0022-538X. PMC 2898230. PMID 20463080.
Guo, Fei; Cen, Shan; Niu, Meijuan; Saadatmand, Jenan; Kleiman, Lawrence (2006-12-01). “Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication” (英語). Journal of Virology 80 (23): 11710–11722. doi:10.1128/JVI.01038-06. ISSN 0022-538X. PMC 1642613. PMID 16971427.
Langlois, Marc-André; Neuberger, Michael S. (2008-05-01). “Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1” (英語). Journal of Virology 82 (9): 4660–4664. doi:10.1128/JVI.02469-07. ISSN 0022-538X. PMC 2293047. PMID 18272574. https://jvi.asm.org/content/82/9/4660.

doi.org

Sheehy AM, Gaddis NC, Choi JD, Malim MH (August 2002). “Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein”. Nature 418 (6898): 646–50. Bibcode: 2002Natur.418..646S. doi:10.1038/nature00939. PMID 12167863.
高折晃史「APOBEC3ファミリー蛋白」『ウイルス』第55巻第2号、2005年12月、267–72頁、doi:10.2222/jsv.55.267、PMID 16557012。
Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). “Structural features of antiviral DNA cytidine deaminases”. Biological Chemistry 394 (11): 1357–70. doi:10.1515/hsz-2013-0165. PMID 23787464.
Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K, et al. (March 2008). “Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G”. Nature 452 (7183): 116–9. Bibcode: 2008Natur.452..116C. doi:10.1038/nature06638. PMID 18288108.
Shandilya SM, Nalam MN, Nalivaika EA, Gross PJ, Valesano JC, Shindo K, et al. (January 2010). “Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces”. Structure 18 (1): 28–38. doi:10.1016/j.str.2009.10.016. PMC 2913127. PMID 20152150.
Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, et al. (November 2008). “Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications”. Nature 456 (7218): 121–4. Bibcode: 2008Natur.456..121H. doi:10.1038/nature07357. PMC 2714533. PMID 18849968.
Furukawa A, Nagata T, Matsugami A, Habu Y, Sugiyama R, Hayashi F, et al. (February 2009). “Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G”. The EMBO Journal 28 (4): 440–51. doi:10.1038/emboj.2008.290. PMC 2646150. PMID 19153609.
Harjes E, Gross PJ, Chen KM, Lu Y, Shindo K, Nowarski R, et al. (June 2009). “An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model”. Journal of Molecular Biology 389 (5): 819–32. doi:10.1016/j.jmb.2009.04.031. PMC 2700007. PMID 19389408.
Li M, Shandilya SM, Carpenter MA, Rathore A, Brown WL, Perkins AL, et al. (March 2012). “First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G”. ACS Chemical Biology 7 (3): 506–17. doi:10.1021/cb200440y. PMC 3306499. PMID 22181350.
Harris RS, Liddament MT (November 2004). “Retroviral restriction by APOBEC proteins”. Nature Reviews. Immunology 4 (11): 868–77. doi:10.1038/nri1489. PMID 15516966.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT (July 2008). “The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation”. Virology 377 (1): 49–53. doi:10.1016/j.virol.2008.04.017. PMC 2474554. PMID 18499212.
Jaguva Vasudevan AA, Perkovic M, Bulliard Y, Cichutek K, Trono D, Häussinger D, Münk C (August 2013). “Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G”. Journal of Virology 87 (16): 9030–40. doi:10.1128/JVI.03385-12. PMC 3754047. PMID 23760237.
Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, et al. (May 2018). “Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential”. Retrovirology 15 (1): 38. doi:10.1186/s12977-018-0419-0. PMC 5956581. PMID 29769087.
Jarmuz, Adam; Chester, Ann; Bayliss, Jayne; Gisbourne, Jane; Dunham, Ian; Scott, James; Navaratnam, Naveenan (2002-03-01). “An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22” (英語). Genomics 79 (3): 285–296. doi:10.1006/geno.2002.6718. ISSN 0888-7543.
Greene, Warner C.; Debyser, Zeger; Ikeda, Yasuhiro; Freed, Eric O.; Stephens, Edward; Yonemoto, Wes; Buckheit, Robert W.; Esté, José A. et al. (2008-12-01). “Novel targets for HIV therapy” (英語). Antiviral Research 80 (3): 251–265. doi:10.1016/j.antiviral.2008.08.003. ISSN 0166-3542.
Huthoff H, Malim MH (2005-04-10). “Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins” (英語). Virology 334 (2): 147–153. doi:10.1016/j.virol.2005.01.038. ISSN 0042-6822.
Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F. (2010-05). “Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G”. Journal of Biological Chemistry 285 (21): 16195–16205. doi:10.1074/jbc.m110.107987. ISSN 0021-9258. PMC 2871487. PMID 20212048.
Li X, Ma J, Zhang Q, Zhou J, Yin X, Zhai C, et al. (2011-06-05). “Functional analysis of the two cytidine deaminase domains in APOBEC3G” (英語). Virology 414 (2): 130–136. doi:10.1016/j.virol.2011.03.014. ISSN 0042-6822.
Mariani, Roberto; Chen, Darlene; Schröfelbauer, Bärbel; Navarro, Francisco; König, Renate; Bollman, Brooke; Münk, Carsten; Nymark-McMahon, Henrietta et al. (2003-07). “Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif”. Cell 114 (1): 21–31. doi:10.1016/s0092-8674(03)00515-4. ISSN 0092-8674.
Xu, Hongzhan; Svarovskaia, Evguenia S.; Barr, Rebekah; Zhang, Yijun; Khan, Mohammad A.; Strebel, Klaus; Pathak, Vinay K. (2004-04-13). “A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion” (英語). Proceedings of the National Academy of Sciences 101 (15): 5652–5657. doi:10.1073/pnas.0400830101. ISSN 0027-8424. PMC 397464. PMID 15054139.
Huthoff, Hendrik; Malim, Michael H. (2007-04-15). “Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation” (英語). Journal of Virology 81 (8): 3807–3815. doi:10.1128/JVI.02795-06. ISSN 0022-538X. PMC 1866099. PMID 17267497. https://jvi.asm.org/content/81/8/3807.
Mbisa, Jean L.; Barr, Rebekah; Thomas, James A.; Vandegraaff, Nick; Dorweiler, Irene J.; Svarovskaia, Evguenia S.; Brown, William L.; Mansky, Louis M. et al. (2007-07-01). “Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration” (英語). Journal of Virology 81 (13): 7099–7110. doi:10.1128/JVI.00272-07. ISSN 0022-538X. PMC 1933301. PMID 17428871.
Neuberger, Michael S.; Harris, Reuben S.; Di Noia, Javier; Petersen-Mahrt, Svend K. (2003-06). “Immunity through DNA deamination”. Trends in Biochemical Sciences 28 (6): 305–312. doi:10.1016/s0968-0004(03)00111-7. ISSN 0968-0004.
Sadler, Holly A.; Stenglein, Mark D.; Harris, Reuben S.; Mansky, Louis M. (2010-07-15). “APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis” (英語). Journal of Virology 84 (14): 7396–7404. doi:10.1128/JVI.00056-10. ISSN 0022-538X. PMC 2898230. PMID 20463080.
Goila-Gaur, Ritu; Strebel, Klaus (2008-06-24). “HIV-1 Vif, APOBEC, and Intrinsic Immunity”. Retrovirology 5 (1): 51. doi:10.1186/1742-4690-5-51. ISSN 1742-4690. PMC 2443170. PMID 18577210.
Guo, Fei; Cen, Shan; Niu, Meijuan; Saadatmand, Jenan; Kleiman, Lawrence (2006-12-01). “Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication” (英語). Journal of Virology 80 (23): 11710–11722. doi:10.1128/JVI.01038-06. ISSN 0022-538X. PMC 1642613. PMID 16971427.
Langlois, Marc-André; Neuberger, Michael S. (2008-05-01). “Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1” (英語). Journal of Virology 82 (9): 4660–4664. doi:10.1128/JVI.02469-07. ISSN 0022-538X. PMC 2293047. PMID 18272574. https://jvi.asm.org/content/82/9/4660.
Neuberger, Michael S.; Harris, Reuben S.; Di Noia, Javier; Petersen-Mahrt, Svend K. (2003-06). “Immunity through DNA deamination”. Trends in Biochemical Sciences 28 (6): 305–312. doi:10.1016/s0968-0004(03)00111-7. ISSN 0968-0004.
“APOBEC3G encapsidation into HIV-1 virions: which RNA is it?”. Retrovirology 5 (55): 55. (July 2008). doi:10.1186/1742-4690-5-55. PMC 2491656. PMID 18597677.

ensembl.org

May2017.archive.ensembl.org

GRCm38: Ensembl release 89: ENSMUSG00000009585 - Ensembl, May 2017

fz-juelich.de

juser.fz-juelich.de

Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). “Structural features of antiviral DNA cytidine deaminases”. Biological Chemistry 394 (11): 1357–70. doi:10.1515/hsz-2013-0165. PMID 23787464.

harvard.edu

ui.adsabs.harvard.edu

Sheehy AM, Gaddis NC, Choi JD, Malim MH (August 2002). “Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein”. Nature 418 (6898): 646–50. Bibcode: 2002Natur.418..646S. doi:10.1038/nature00939. PMID 12167863.
Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K, et al. (March 2008). “Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G”. Nature 452 (7183): 116–9. Bibcode: 2008Natur.452..116C. doi:10.1038/nature06638. PMID 18288108.
Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, et al. (November 2008). “Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications”. Nature 456 (7218): 121–4. Bibcode: 2008Natur.456..121H. doi:10.1038/nature07357. PMC 2714533. PMID 18849968.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sheehy AM, Gaddis NC, Choi JD, Malim MH (August 2002). “Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein”. Nature 418 (6898): 646–50. Bibcode: 2002Natur.418..646S. doi:10.1038/nature00939. PMID 12167863.
高折晃史「APOBEC3ファミリー蛋白」『ウイルス』第55巻第2号、2005年12月、267–72頁、doi:10.2222/jsv.55.267、PMID 16557012。
Vasudevan AA, Smits SH, Höppner A, Häussinger D, Koenig BW, Münk C (November 2013). “Structural features of antiviral DNA cytidine deaminases”. Biological Chemistry 394 (11): 1357–70. doi:10.1515/hsz-2013-0165. PMID 23787464.
Chen KM, Harjes E, Gross PJ, Fahmy A, Lu Y, Shindo K, et al. (March 2008). “Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G”. Nature 452 (7183): 116–9. Bibcode: 2008Natur.452..116C. doi:10.1038/nature06638. PMID 18288108.
Shandilya SM, Nalam MN, Nalivaika EA, Gross PJ, Valesano JC, Shindo K, et al. (January 2010). “Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces”. Structure 18 (1): 28–38. doi:10.1016/j.str.2009.10.016. PMC 2913127. PMID 20152150.
Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, et al. (November 2008). “Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications”. Nature 456 (7218): 121–4. Bibcode: 2008Natur.456..121H. doi:10.1038/nature07357. PMC 2714533. PMID 18849968.
Furukawa A, Nagata T, Matsugami A, Habu Y, Sugiyama R, Hayashi F, et al. (February 2009). “Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G”. The EMBO Journal 28 (4): 440–51. doi:10.1038/emboj.2008.290. PMC 2646150. PMID 19153609.
Harjes E, Gross PJ, Chen KM, Lu Y, Shindo K, Nowarski R, et al. (June 2009). “An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model”. Journal of Molecular Biology 389 (5): 819–32. doi:10.1016/j.jmb.2009.04.031. PMC 2700007. PMID 19389408.
Li M, Shandilya SM, Carpenter MA, Rathore A, Brown WL, Perkins AL, et al. (March 2012). “First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G”. ACS Chemical Biology 7 (3): 506–17. doi:10.1021/cb200440y. PMC 3306499. PMID 22181350.
Harris RS, Liddament MT (November 2004). “Retroviral restriction by APOBEC proteins”. Nature Reviews. Immunology 4 (11): 868–77. doi:10.1038/nri1489. PMID 15516966.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT (July 2008). “The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation”. Virology 377 (1): 49–53. doi:10.1016/j.virol.2008.04.017. PMC 2474554. PMID 18499212.
Jaguva Vasudevan AA, Perkovic M, Bulliard Y, Cichutek K, Trono D, Häussinger D, Münk C (August 2013). “Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G”. Journal of Virology 87 (16): 9030–40. doi:10.1128/JVI.03385-12. PMC 3754047. PMID 23760237.
Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, et al. (May 2018). “Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential”. Retrovirology 15 (1): 38. doi:10.1186/s12977-018-0419-0. PMC 5956581. PMID 29769087.
Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F. (2010-05). “Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G”. Journal of Biological Chemistry 285 (21): 16195–16205. doi:10.1074/jbc.m110.107987. ISSN 0021-9258. PMC 2871487. PMID 20212048.
Xu, Hongzhan; Svarovskaia, Evguenia S.; Barr, Rebekah; Zhang, Yijun; Khan, Mohammad A.; Strebel, Klaus; Pathak, Vinay K. (2004-04-13). “A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion” (英語). Proceedings of the National Academy of Sciences 101 (15): 5652–5657. doi:10.1073/pnas.0400830101. ISSN 0027-8424. PMC 397464. PMID 15054139.
Huthoff, Hendrik; Malim, Michael H. (2007-04-15). “Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation” (英語). Journal of Virology 81 (8): 3807–3815. doi:10.1128/JVI.02795-06. ISSN 0022-538X. PMC 1866099. PMID 17267497. https://jvi.asm.org/content/81/8/3807.
Mbisa, Jean L.; Barr, Rebekah; Thomas, James A.; Vandegraaff, Nick; Dorweiler, Irene J.; Svarovskaia, Evguenia S.; Brown, William L.; Mansky, Louis M. et al. (2007-07-01). “Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration” (英語). Journal of Virology 81 (13): 7099–7110. doi:10.1128/JVI.00272-07. ISSN 0022-538X. PMC 1933301. PMID 17428871.
Sadler, Holly A.; Stenglein, Mark D.; Harris, Reuben S.; Mansky, Louis M. (2010-07-15). “APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis” (英語). Journal of Virology 84 (14): 7396–7404. doi:10.1128/JVI.00056-10. ISSN 0022-538X. PMC 2898230. PMID 20463080.
Goila-Gaur, Ritu; Strebel, Klaus (2008-06-24). “HIV-1 Vif, APOBEC, and Intrinsic Immunity”. Retrovirology 5 (1): 51. doi:10.1186/1742-4690-5-51. ISSN 1742-4690. PMC 2443170. PMID 18577210.
Guo, Fei; Cen, Shan; Niu, Meijuan; Saadatmand, Jenan; Kleiman, Lawrence (2006-12-01). “Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication” (英語). Journal of Virology 80 (23): 11710–11722. doi:10.1128/JVI.01038-06. ISSN 0022-538X. PMC 1642613. PMID 16971427.
Langlois, Marc-André; Neuberger, Michael S. (2008-05-01). “Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1” (英語). Journal of Virology 82 (9): 4660–4664. doi:10.1128/JVI.02469-07. ISSN 0022-538X. PMC 2293047. PMID 18272574. https://jvi.asm.org/content/82/9/4660.
Wissing S, Galloway NL, Greene WC (2010). “HIV-1 Vif Versus the APOBEC3 Cytidine Deaminases: An Intracellular Duel Between Pathogen and Host Restriction Factors”. Molecular Aspects of Medicine 31: 383-397. PMID 18597677.
“APOBEC3G encapsidation into HIV-1 virions: which RNA is it?”. Retrovirology 5 (55): 55. (July 2008). doi:10.1186/1742-4690-5-55. PMC 2491656. PMID 18597677.
Xu H, Chertova E, Chen J, Ott DE, Roser JD, Hu WS, Pathak VK (2007). “Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions”. Virology 360: 247-256. PMID 17126871.
Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, et al. (2008). “Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences”. Journal of Virology 82: 8743-8761. PMID 18562517.
Lee YN, Malim MH, Bieniasz PD (2008). “Hypermutation of an Ancient Human Retrovirus by APOBEC3G”. Journal of Virology 82: 8762–8770. PMID 15383144.
Goncalves J, Santa-Marta M (2004). “HIV-1 Vif and APOBEC3G: Multiple roads to one goal”. Retrovirology 1: 28. PMID 15383144.
Pillai SK, Wong JK, Barbour JD (2008). “Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)”. Retrovirology 5: 26. PMID 18339206.
Mulder LC, Harari A, Simon V (2008). “Cytidine deamination induced HIV-1 drug resistance”. Proceedings of the National Academy of Sciences of the United States of America 105: 5501-5506. PMID 18391217.

pmc.ncbi.nlm.nih.gov

Shandilya SM, Nalam MN, Nalivaika EA, Gross PJ, Valesano JC, Shindo K, et al. (January 2010). “Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces”. Structure 18 (1): 28–38. doi:10.1016/j.str.2009.10.016. PMC 2913127. PMID 20152150.
Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, et al. (November 2008). “Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications”. Nature 456 (7218): 121–4. Bibcode: 2008Natur.456..121H. doi:10.1038/nature07357. PMC 2714533. PMID 18849968.
Furukawa A, Nagata T, Matsugami A, Habu Y, Sugiyama R, Hayashi F, et al. (February 2009). “Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G”. The EMBO Journal 28 (4): 440–51. doi:10.1038/emboj.2008.290. PMC 2646150. PMID 19153609.
Harjes E, Gross PJ, Chen KM, Lu Y, Shindo K, Nowarski R, et al. (June 2009). “An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model”. Journal of Molecular Biology 389 (5): 819–32. doi:10.1016/j.jmb.2009.04.031. PMC 2700007. PMID 19389408.
Li M, Shandilya SM, Carpenter MA, Rathore A, Brown WL, Perkins AL, et al. (March 2012). “First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G”. ACS Chemical Biology 7 (3): 506–17. doi:10.1021/cb200440y. PMC 3306499. PMID 22181350.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT (July 2008). “The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation”. Virology 377 (1): 49–53. doi:10.1016/j.virol.2008.04.017. PMC 2474554. PMID 18499212.
Jaguva Vasudevan AA, Perkovic M, Bulliard Y, Cichutek K, Trono D, Häussinger D, Münk C (August 2013). “Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G”. Journal of Virology 87 (16): 9030–40. doi:10.1128/JVI.03385-12. PMC 3754047. PMID 23760237.
Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, et al. (May 2018). “Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential”. Retrovirology 15 (1): 38. doi:10.1186/s12977-018-0419-0. PMC 5956581. PMID 29769087.
Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F. (2010-05). “Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G”. Journal of Biological Chemistry 285 (21): 16195–16205. doi:10.1074/jbc.m110.107987. ISSN 0021-9258. PMC 2871487. PMID 20212048.
Xu, Hongzhan; Svarovskaia, Evguenia S.; Barr, Rebekah; Zhang, Yijun; Khan, Mohammad A.; Strebel, Klaus; Pathak, Vinay K. (2004-04-13). “A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion” (英語). Proceedings of the National Academy of Sciences 101 (15): 5652–5657. doi:10.1073/pnas.0400830101. ISSN 0027-8424. PMC 397464. PMID 15054139.
Huthoff, Hendrik; Malim, Michael H. (2007-04-15). “Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation” (英語). Journal of Virology 81 (8): 3807–3815. doi:10.1128/JVI.02795-06. ISSN 0022-538X. PMC 1866099. PMID 17267497. https://jvi.asm.org/content/81/8/3807.
Mbisa, Jean L.; Barr, Rebekah; Thomas, James A.; Vandegraaff, Nick; Dorweiler, Irene J.; Svarovskaia, Evguenia S.; Brown, William L.; Mansky, Louis M. et al. (2007-07-01). “Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration” (英語). Journal of Virology 81 (13): 7099–7110. doi:10.1128/JVI.00272-07. ISSN 0022-538X. PMC 1933301. PMID 17428871.
Sadler, Holly A.; Stenglein, Mark D.; Harris, Reuben S.; Mansky, Louis M. (2010-07-15). “APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis” (英語). Journal of Virology 84 (14): 7396–7404. doi:10.1128/JVI.00056-10. ISSN 0022-538X. PMC 2898230. PMID 20463080.
Goila-Gaur, Ritu; Strebel, Klaus (2008-06-24). “HIV-1 Vif, APOBEC, and Intrinsic Immunity”. Retrovirology 5 (1): 51. doi:10.1186/1742-4690-5-51. ISSN 1742-4690. PMC 2443170. PMID 18577210.
Guo, Fei; Cen, Shan; Niu, Meijuan; Saadatmand, Jenan; Kleiman, Lawrence (2006-12-01). “Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication” (英語). Journal of Virology 80 (23): 11710–11722. doi:10.1128/JVI.01038-06. ISSN 0022-538X. PMC 1642613. PMID 16971427.
Langlois, Marc-André; Neuberger, Michael S. (2008-05-01). “Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1” (英語). Journal of Virology 82 (9): 4660–4664. doi:10.1128/JVI.02469-07. ISSN 0022-538X. PMC 2293047. PMID 18272574. https://jvi.asm.org/content/82/9/4660.
“APOBEC3G encapsidation into HIV-1 virions: which RNA is it?”. Retrovirology 5 (55): 55. (July 2008). doi:10.1186/1742-4690-5-55. PMC 2491656. PMID 18597677.

ncbi.nlm.nih.gov

Human PubMed Reference:
Mouse PubMed Reference:
Shandilya SM, Nalam MN, Nalivaika EA, Gross PJ, Valesano JC, Shindo K, et al. (January 2010). “Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces”. Structure 18 (1): 28–38. doi:10.1016/j.str.2009.10.016. PMC 2913127. PMID 20152150.
Holden LG, Prochnow C, Chang YP, Bransteitter R, Chelico L, Sen U, et al. (November 2008). “Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications”. Nature 456 (7218): 121–4. Bibcode: 2008Natur.456..121H. doi:10.1038/nature07357. PMC 2714533. PMID 18849968.
Furukawa A, Nagata T, Matsugami A, Habu Y, Sugiyama R, Hayashi F, et al. (February 2009). “Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G”. The EMBO Journal 28 (4): 440–51. doi:10.1038/emboj.2008.290. PMC 2646150. PMID 19153609.
Harjes E, Gross PJ, Chen KM, Lu Y, Shindo K, Nowarski R, et al. (June 2009). “An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model”. Journal of Molecular Biology 389 (5): 819–32. doi:10.1016/j.jmb.2009.04.031. PMC 2700007. PMID 19389408.
Li M, Shandilya SM, Carpenter MA, Rathore A, Brown WL, Perkins AL, et al. (March 2012). “First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G”. ACS Chemical Biology 7 (3): 506–17. doi:10.1021/cb200440y. PMC 3306499. PMID 22181350.
Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT (July 2008). “The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation”. Virology 377 (1): 49–53. doi:10.1016/j.virol.2008.04.017. PMC 2474554. PMID 18499212.
Jaguva Vasudevan AA, Perkovic M, Bulliard Y, Cichutek K, Trono D, Häussinger D, Münk C (August 2013). “Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G”. Journal of Virology 87 (16): 9030–40. doi:10.1128/JVI.03385-12. PMC 3754047. PMID 23760237.
Ledesma-Feliciano C, Hagen S, Troyer R, Zheng X, Musselman E, Slavkovic Lukic D, et al. (May 2018). “Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential”. Retrovirology 15 (1): 38. doi:10.1186/s12977-018-0419-0. PMC 5956581. PMID 29769087.
“APOBEC3G encapsidation into HIV-1 virions: which RNA is it?”. Retrovirology 5 (55): 55. (July 2008). doi:10.1186/1742-4690-5-55. PMC 2491656. PMID 18597677.

pnas.org

Xu, Hongzhan; Svarovskaia, Evguenia S.; Barr, Rebekah; Zhang, Yijun; Khan, Mohammad A.; Strebel, Klaus; Pathak, Vinay K. (2004-04-13). “A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion” (英語). Proceedings of the National Academy of Sciences 101 (15): 5652–5657. doi:10.1073/pnas.0400830101. ISSN 0027-8424. PMC 397464. PMID 15054139.

sciencedirect.com

Jarmuz, Adam; Chester, Ann; Bayliss, Jayne; Gisbourne, Jane; Dunham, Ian; Scott, James; Navaratnam, Naveenan (2002-03-01). “An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22” (英語). Genomics 79 (3): 285–296. doi:10.1006/geno.2002.6718. ISSN 0888-7543.
Greene, Warner C.; Debyser, Zeger; Ikeda, Yasuhiro; Freed, Eric O.; Stephens, Edward; Yonemoto, Wes; Buckheit, Robert W.; Esté, José A. et al. (2008-12-01). “Novel targets for HIV therapy” (英語). Antiviral Research 80 (3): 251–265. doi:10.1016/j.antiviral.2008.08.003. ISSN 0166-3542.
Huthoff H, Malim MH (2005-04-10). “Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins” (英語). Virology 334 (2): 147–153. doi:10.1016/j.virol.2005.01.038. ISSN 0042-6822.
Li X, Ma J, Zhang Q, Zhou J, Yin X, Zhai C, et al. (2011-06-05). “Functional analysis of the two cytidine deaminase domains in APOBEC3G” (英語). Virology 414 (2): 130–136. doi:10.1016/j.virol.2011.03.014. ISSN 0042-6822.

wikipedia.org

en.wikipedia.org

GRCm38: Ensembl release 89: ENSMUSG00000009585 - Ensembl, May 2017

worldcat.org

search.worldcat.org

Jarmuz, Adam; Chester, Ann; Bayliss, Jayne; Gisbourne, Jane; Dunham, Ian; Scott, James; Navaratnam, Naveenan (2002-03-01). “An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22” (英語). Genomics 79 (3): 285–296. doi:10.1006/geno.2002.6718. ISSN 0888-7543.
Greene, Warner C.; Debyser, Zeger; Ikeda, Yasuhiro; Freed, Eric O.; Stephens, Edward; Yonemoto, Wes; Buckheit, Robert W.; Esté, José A. et al. (2008-12-01). “Novel targets for HIV therapy” (英語). Antiviral Research 80 (3): 251–265. doi:10.1016/j.antiviral.2008.08.003. ISSN 0166-3542.
Huthoff H, Malim MH (2005-04-10). “Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins” (英語). Virology 334 (2): 147–153. doi:10.1016/j.virol.2005.01.038. ISSN 0042-6822.
Chelico, Linda; Prochnow, Courtney; Erie, Dorothy A.; Chen, Xiaojiang S.; Goodman, Myron F. (2010-05). “Structural Model for Deoxycytidine Deamination Mechanisms of the HIV-1 Inactivation Enzyme APOBEC3G”. Journal of Biological Chemistry 285 (21): 16195–16205. doi:10.1074/jbc.m110.107987. ISSN 0021-9258. PMC 2871487. PMID 20212048.
Li X, Ma J, Zhang Q, Zhou J, Yin X, Zhai C, et al. (2011-06-05). “Functional analysis of the two cytidine deaminase domains in APOBEC3G” (英語). Virology 414 (2): 130–136. doi:10.1016/j.virol.2011.03.014. ISSN 0042-6822.
Mariani, Roberto; Chen, Darlene; Schröfelbauer, Bärbel; Navarro, Francisco; König, Renate; Bollman, Brooke; Münk, Carsten; Nymark-McMahon, Henrietta et al. (2003-07). “Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif”. Cell 114 (1): 21–31. doi:10.1016/s0092-8674(03)00515-4. ISSN 0092-8674.
Xu, Hongzhan; Svarovskaia, Evguenia S.; Barr, Rebekah; Zhang, Yijun; Khan, Mohammad A.; Strebel, Klaus; Pathak, Vinay K. (2004-04-13). “A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion” (英語). Proceedings of the National Academy of Sciences 101 (15): 5652–5657. doi:10.1073/pnas.0400830101. ISSN 0027-8424. PMC 397464. PMID 15054139.
Huthoff, Hendrik; Malim, Michael H. (2007-04-15). “Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation” (英語). Journal of Virology 81 (8): 3807–3815. doi:10.1128/JVI.02795-06. ISSN 0022-538X. PMC 1866099. PMID 17267497. https://jvi.asm.org/content/81/8/3807.
Mbisa, Jean L.; Barr, Rebekah; Thomas, James A.; Vandegraaff, Nick; Dorweiler, Irene J.; Svarovskaia, Evguenia S.; Brown, William L.; Mansky, Louis M. et al. (2007-07-01). “Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration” (英語). Journal of Virology 81 (13): 7099–7110. doi:10.1128/JVI.00272-07. ISSN 0022-538X. PMC 1933301. PMID 17428871.
Neuberger, Michael S.; Harris, Reuben S.; Di Noia, Javier; Petersen-Mahrt, Svend K. (2003-06). “Immunity through DNA deamination”. Trends in Biochemical Sciences 28 (6): 305–312. doi:10.1016/s0968-0004(03)00111-7. ISSN 0968-0004.
Sadler, Holly A.; Stenglein, Mark D.; Harris, Reuben S.; Mansky, Louis M. (2010-07-15). “APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis” (英語). Journal of Virology 84 (14): 7396–7404. doi:10.1128/JVI.00056-10. ISSN 0022-538X. PMC 2898230. PMID 20463080.
Goila-Gaur, Ritu; Strebel, Klaus (2008-06-24). “HIV-1 Vif, APOBEC, and Intrinsic Immunity”. Retrovirology 5 (1): 51. doi:10.1186/1742-4690-5-51. ISSN 1742-4690. PMC 2443170. PMID 18577210.
Guo, Fei; Cen, Shan; Niu, Meijuan; Saadatmand, Jenan; Kleiman, Lawrence (2006-12-01). “Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication” (英語). Journal of Virology 80 (23): 11710–11722. doi:10.1128/JVI.01038-06. ISSN 0022-538X. PMC 1642613. PMID 16971427.
Langlois, Marc-André; Neuberger, Michael S. (2008-05-01). “Human APOBEC3G Can Restrict Retroviral Infection in Avian Cells and Acts Independently of both UNG and SMUG1” (英語). Journal of Virology 82 (9): 4660–4664. doi:10.1128/JVI.02469-07. ISSN 0022-538X. PMC 2293047. PMID 18272574. https://jvi.asm.org/content/82/9/4660.
Neuberger, Michael S.; Harris, Reuben S.; Di Noia, Javier; Petersen-Mahrt, Svend K. (2003-06). “Immunity through DNA deamination”. Trends in Biochemical Sciences 28 (6): 305–312. doi:10.1016/s0968-0004(03)00111-7. ISSN 0968-0004.